Director of Intellectual Property — CSL Behring

Panoramica

The Director of Intellectual Property provides strategic support to CSL Research and Technical Operations organizations, with a primary responsibility for Tech Ops activities in Bern and Research in Schlieren (Zurich). In particular, the role will support CSL plasma and recombinant platforms within Technical Operations and Translational Research activities.

The Director of IP is responsible for identifying, protecting, managing, patent, trade secrets, exclusivities of all types and related intellectual property (IP) matters. Additionally, the Director of IP assesses patentability of inventions, potential infringement of patents and exclusivities, agreements involving patents, know-how, trade secrets and other exclusivity rights, and management of third-party IP risk. The position will work with some independence within the Global IP matrix work model to prepare, prosecute, maintain applications for the global patent portfolio, defend and enforce IP rights and partner with stakeholders and other CSL functions to maximize the value of IP for CSL.

• Manage and deliver global patent and related intellectual property strategies and support for significant portion of CSL Group’s global activities, especially relevant to CSL Research and Technical Operations. Acts as primary IP contact for Technical Operations in respect of Albumin, Fractionation + Horizon 2 and local nominated Integrated Product Teams (IPTs) such as Ig/Inframarginals, Recombinants and Iron. The role will also serve as the IP advisor to selected European-based Research functions, including Drug Discovery, Translational & Data Science, Non-Clinical Development and associated project teams.

• Manage prosecution and defense of CSL intellectual property by supporting projects from early drug discovery to launch and beyond, including creating and safeguarding of a patent portfolio tailored to CSL’s activities with respect to pending applications and granted patents considering national and international laws and guidelines.

• Contributes to the delivery of enterprise-wide IP strategy for new and existing development-stage products, including optimizing and defending regulatory exclusivities and lifecycle management activities.

• Drive strategic patent filings for key Swiss-owned products (e.g. Privigen, Alburx) to maximise Swiss Patent Box benefits.

• Partner with European-based Research leadership to develop and implement IP strategies supporting pre-clinical programs, platform technologies and translational research activities across key therapeutic areas including Haematology, Cardiovascular & Renal, and Transplant & Immunology, Vaccines and Immunoglobulins.

• Contribute to the identification and preservation of Trade Secrets and, in conjunction with IP team, ensure trade secrets are well protected within the Global IP strategy alongside other IP rights.

• Lead invention harvesting, patent filing and portfolio development activities arising from Research and Technical Operations initiatives, including core technology platforms, manufacturing innovations, analytical methods, formulations, product improvements and next-generation product opportunities.

• Provide freedom to operate analysis across elected countries for assigned portfolio related risks, developing risk mitigation strategies and options and communicating to management and stakeholders.

Domande frequenti su questo annuncio